Cubist Systematic Strategies, LLC 23and Me Holding Co. Transaction History

Cubist Systematic Strategies, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.29 - $0.51 $7,426 - $13,060	-25,608 Reduced 54.02%	21,799 $7,000
Q2 2024 Aug 14, 2024	BUY	$0.36 - $0.61 $17,066 - $28,918	47,407 New	47,407 $18,000
Q4 2023 Feb 14, 2024	BUY	$0.71 - $0.97 $81,774 - $111,720	115,176 New	115,176 $104,000
Q4 2022 Feb 14, 2023	BUY	$2.06 - $3.47 $576,146 - $970,500	279,683 New	279,683 $604,000
Q2 2022 Aug 15, 2022	SELL	$2.19 - $3.98 $1.24 Million - $2.25 Million	-565,620 Reduced 91.58%	52,036 $129,000
Q1 2022 May 16, 2022	BUY	$3.28 - $7.12 $1.07 Million - $2.31 Million	324,760 Added 110.88%	617,656 $2.37 Million
Q4 2021 Feb 14, 2022	BUY	$6.55 - $13.25 $1.17 Million - $2.37 Million	179,208 Added 157.63%	292,896 $1.95 Million
Q3 2021 Nov 15, 2021	BUY	$7.29 - $11.0 $828,785 - $1.25 Million	113,688 New	113,688 $1.03 Million

8.42M

50K

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $387M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.